ArticleJournal of hematology & oncology2022

A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors.

Pan Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.